This study is testing a behavioral intervention called the "Partner Navigation Intervention" to help young people who inject drugs start treatment for Hepatitis C (HCV). This intervention involves two sessions led by a disclosure counselor, designed to help an injecting partner support the person with HCV to begin treatment. You may be able to join if you are an adult who has injected drugs in the past month, have a primary injecting partner, and have recently been diagnosed with HCV. The study will look at how well this intervention works by measuring if people start HCV treatment at 6, 12, and 24 months after learning they have HCV. The current status of this study is unclear, and it plans to enroll 500 people.

Study design

This is a randomized controlled study, meaning participants will be assigned by chance to either receive the intervention or standard care. The study plans to enroll 500 participants, including 250 people with HCV and their injecting partners.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 6 months, 12 months, and 24 months after their HCV infection disclosure visit to see if they started treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.